Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.23.2
Stock-based Compensation (Tables)
 6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense

We recorded stock-based compensation expense for the three and six months ended June 30, 2023 and 2022 as follows:

 

    2023     2022     2023     2022  
    Three Months Ended
June 30,		     Six Months Ended
June 30,		  
    2023     2022     2023     2022  
Research and development   $ 102,678     $ 685,624     $ 209,526     $ 877,500  
General and administrative     216,445       1,323,745       451,101       1,960,766  
Total   $ 319,123     $ 2,009,369     $ 660,627     $ 2,838,266  
Schedule of Restricted Stock Awards (“RSAs”) Activity

Activity with respect to our Restricted Stock Awards (RSAs) during the six months ended June 30, 2023 was as follows:

 

    Number of
shares		     Weighted-
average
grant-date fair
value per share		  
Outstanding at January 1, 2023     61,888     $ 4.72  
Granted     90,000       1.10  
Cancelled     (26,118 )     1.72  
Issued     (100,770 )     1.79  
                 
Outstanding and unvested at June 30, 2023     25,000     $ 6.65  
Schedule of Restricted Stock Units (“RSUs”) Activity

Activity with respect to our Restricted Stock Units (“RSUs”) during the six months ended June 30, 2023 was as follows:

 

    Number of
shares		     Weighted-
average
grant-date fair
value per share		  
Outstanding at January 1, 2023     2,713,977     $ 3.69  
Granted     1,473,328       0.90  
Cancelled     (44,395 )     1.63  
Outstanding at June 30, 2023     4,142,910       2.72  
Vested and unissued     2,590,497       3.51  
                 
Unvested at June 30, 2023     1,552,413     $ 1.41